TipRanks
Insperity Inc (NSP)
NYSE:NSP
Want to see NSP full AI Analyst Report?

Insperity (NSP) AI Stock Analysis

399 Followers

Top Page

NSP

Insperity

(NYSE:NSP)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - Gpt-5.6Sol)
Rating:58Neutral
Price Target:
$49.00
▼(-8.48% Downside)
Action:Reiterated
Date:07/30/26
NSP’s score is held back primarily by weakened profitability and elevated leverage despite strong TTM revenue growth and a sharp rebound in free cash flow. Technicals are a meaningful positive with the stock trading well above major moving averages. Valuation is mixed (high dividend yield but negative P/E due to losses), while the earnings call points to margin recovery progress and reiterated EBITDA guidance tempered by ongoing unit declines and weaker new sales.
Positive Factors
Strong revenue growth
Revenue growth of roughly 41% indicates strong demand for Insperity’s HR outsourcing services and expanding client-related activity. If sustained, greater payroll and worksite-employee scale can support recurring service revenue, improve platform utilization, and create operating leverage over the next several quarters.
Negative Factors
Profitability deterioration
Insperity’s strong revenue growth is not yet translating into durable earnings, as recent losses and significant gross-margin compression indicate weaker operating leverage. Continued pressure on benefit costs, pricing, or service economics could limit reinvestment capacity and make future earnings less predictable.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Revenue growth of roughly 41% indicates strong demand for Insperity’s HR outsourcing services and expanding client-related activity. If sustained, greater payroll and worksite-employee scale can support recurring service revenue, improve platform utilization, and create operating leverage over the next several quarters.
Read all positive factors

Insperity Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down where Insperity earns sales across regions, highlighting geographic strengths and concentration risk. Regional trends reveal growth opportunities, exposure to local economic cycles or regulatory changes, and where the company’s sales and marketing efforts are most effective.
Chart InsightsRevenue shows a broad, region‑wide rebound concentrated in the Northeast and West, driven more by pricing/mix and improved gross profit per employee than by unit growth. Management’s decision to hold EBITDA guidance while trimming WSE guidance confirms margins—not headcount—are fueling recent gains. HRScale and AI investments offer medium‑term upside, but weaker new sales, elevated attrition and SMB macro concerns could blunt sustainability; monitor revenue per WSE and client retention for signs this margin-led recovery can convert into durable organic growth.
Data provided by:The Fly

Insperity (NSP) vs. SPDR S&P 500 ETF (SPY)

Insperity Business Overview & Revenue Model

Company Description
Insperity, Inc. (NSP) delivers comprehensive human resources and business solutions primarily designed to enhance the operational efficiency and performance of small and medium-sized enterprises. The company's core HR services are provided through...
How the Company Makes Money
Insperity makes money primarily by charging fees tied to worksite employees and the payroll it administers for client companies, with most revenue generated through its PEO services. Under the PEO model, Insperity enters into a co-employment arran...

Insperity Earnings Call Summary

Earnings Call Date:Jul 29, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Oct 29, 2026
Earnings Call Sentiment Neutral
The call showed meaningful progress on margin recovery and operational efficiency—evidenced by improved gross profit trends, controlled operating expenses (ex-restructuring) and stable adjusted EBITDA—alongside promising early traction for HRScale and AI initiatives. Offsetting these positives were continued unit declines (worksite employees and new sales), a 17% drop in adjusted EPS driven in part by a higher effective tax rate and near-term restructuring and investment costs. Management reiterated full-year adjusted EBITDA guidance but lowered unit growth expectations due to weaker SMB sentiment and the deliberate margin-focused sales/renewal approach.
Positive Updates
Adjusted EBITDA Beat and Stability
Adjusted EBITDA of $103.0M in Q1 2026, up 1% versus $102.0M in Q1 2025, and above the midpoint of the company's expected range; full-year adjusted EBITDA guidance reiterated at $170M–$230M.
Negative Updates
Adjusted EPS Decline
Adjusted EPS was $1.31 in Q1 2026, down 17% versus $1.57 in Q1 2025; higher effective tax rate (41% vs 29% in prior year quarter) contributed to the EPS decline.
Read all updates
Q2-2026 Updates
Negative
Adjusted EBITDA Beat and Stability
Adjusted EBITDA of $103.0M in Q1 2026, up 1% versus $102.0M in Q1 2025, and above the midpoint of the company's expected range; full-year adjusted EBITDA guidance reiterated at $170M–$230M.
Read all positive updates
Company Guidance
Management reiterated full-year adjusted EBITDA guidance of $170M–$230M while updating other metrics: Q1 results were adjusted EPS $1.31 and adjusted EBITDA $103M with average paid worksite employees (WSEs) at 303,049 (‑1.0% YoY), total gross profit $302M (‑3%), gross profit per WSE $332/month, benefit cost per covered employee +5% YoY, operating expenses $240M (‑1%; ‑5% ex $9M restructuring), $13M invested in HRScale ($8M opex, $5M capex), dividends paid $23M, 171k shares repurchased for $4M, adjusted cash $36M, and $380M unused credit capacity ($330M borrowable). For the full year 2026 they now forecast average WSEs of 303,000–307,000 (down 1.0%–2.3% vs 2025), adjusted EPS $1.60–$2.60, a 36% effective tax rate and ~38.5M weighted average shares; Q2 guidance is 302,500–304,500 average WSEs (‑1.5% to ‑2.1% YoY), adjusted EBITDA $18M–$46M and adjusted EPS $0.02–$0.50. Management noted the UnitedHealthcare pooling change ($1M to $500k) and margin recovery progress as drivers that should flatten quarterly earnings and help offset lower unit growth.

Insperity Financial Statement Overview

Summary
Financials are mixed: very strong TTM revenue growth (~41%) and a strong rebound in operating/free cash flow (OCF ~$225M; FCF ~$194M) support the score, but profitability has deteriorated into losses (TTM net income -$16M) with sharp margin compression (gross margin ~12.9% vs ~16–17% previously). Balance-sheet leverage is a key risk (debt ~$478M vs equity ~$61M; ~6.4x debt-to-equity), limiting flexibility if margins don’t recover.
Income Statement
46
Neutral
Balance Sheet
34
Negative
Cash Flow
55
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.87B6.81B6.58B6.49B5.94B4.97B
Gross Profit880.00M900.00M1.05B1.04B1.01B820.10M
EBITDA54.00M65.00M198.00M295.00M300.29M214.32M
Net Income-16.00M-7.00M91.00M171.00M179.35M124.08M
Balance Sheet
Total Assets2.23B2.20B2.60B2.12B2.04B1.75B
Cash, Cash Equivalents and Short-Term Investments619.00M660.00M1.05B709.00M765.90M607.60M
Total Debt478.00M435.00M435.00M427.00M424.99M433.59M
Total Liabilities2.17B2.16B2.50B2.03B1.96B1.75B
Stockholders Equity61.00M46.00M97.00M94.00M81.28M-1.77M
Cash Flow
Free Cash Flow275.00M-309.00M482.00M158.37M317.36M227.25M
Operating Cash Flow306.00M-278.00M520.00M198.49M347.69M260.15M
Investing Cash Flow-15.00M-31.00M-38.00M-21.73M-32.12M-31.01M
Financing Cash Flow-10.00M-90.00M-173.00M-155.01M-141.15M-208.07M

Insperity Technical Analysis

Technical Analysis Sentiment
Positive
Last Price53.54
Price Trends
50DMA
50.02
Positive
100DMA
46.77
Positive
200DMA
38.42
Positive
Market Momentum
MACD
0.19
Negative
RSI
53.47
Neutral
STOCH
50.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NSP, the sentiment is Positive. The current price of 53.54 is above the 20-day moving average (MA) of 48.52, above the 50-day MA of 50.02, and above the 200-day MA of 38.42, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 53.47 is Neutral, neither overbought nor oversold. The STOCH value of 50.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NSP.

Insperity Risk Analysis

Insperity disclosed 1 risk factors in its most recent earnings report. Insperity reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Insperity Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$226.85M27.6611.98%1.41%-7.54%237.08%
70
Outperform
$771.41M22.9015.76%1.01%5.59%-33.45%
69
Neutral
$40.05B22.2847.11%4.04%13.97%12.61%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
59
Neutral
$3.26B19.00188.17%1.61%-2.83%26.75%
58
Neutral
$1.91B-119.48-24.52%4.78%2.64%-140.86%
54
Neutral
$2.08B17.305.75%3.23%7.25%―
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NSP
Insperity
50.18
7.15
16.63%
BBSI
Barrett Business Services
31.83
-9.42
-22.84%
MAN
ManpowerGroup
44.64
12.60
39.32%
PAYX
Paychex
112.50
-6.99
-5.85%
TNET
TriNet Group
71.03
9.78
15.96%
HQI
HireQuest
16.32
7.93
94.61%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 30, 2026